CASC9 and hepatocellular carcinoma: Finally, CASC9 and LUCAT1 serum levels were assayed in cirrhotics with (N=28) and without HCC (N=14) and no significant difference was found, ruling out their possible role as diagnostic non-invasive biomarkers (Figure 7F, 7G).